Literature DB >> 20643182

Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration.

Ronald van Os1, Albertina Ausema, Bert Dontje, Manon van Riezen, Gooitzen van Dam, Gerald de Haan.   

Abstract

OBJECTIVE: Hematopoietic stem cells are key elements for life-long production of mature blood cells. The success of clinical stem cell transplantation may be improved when the number of stem cells that engraft after transplantation can be increased. Here, we investigated in a syngeneic mouse model whether engraftment and reconstitution can be improved by transplantation directly into the bone marrow.
MATERIALS AND METHODS: In this study, we directly compared syngeneic transplantation of hematopoietic stem cells into the bone marrow with intravenous administration and assessed reconstitution kinetics and engraftment by bioluminescent imaging and chimerism determination.
RESULTS: Surprisingly, only about 10% of cells injected directly into the femur (intrafemoral, IF) could be retrieved within 5 minutes after injection. Only in the first 48 hours after transplantation, engraftment in IF-transplanted animals was higher compared with intravenous injection. However, at all later time points no differences could be detected using whole body bioluminescence or measuring blood cell reconstitution. Most importantly, we found that IF-transplanted cells did not outcompete cells transplanted intravenously when cotransplanted in the same recipient.
CONCLUSIONS: In conclusion, IF transplantation in a murine syngeneic setting revealed no enhanced engraftment. Previous reports on IF transplantation may have relied on escape from immune rejection in xenogeneic or allogeneic models. Therefore, we conclude that stem cells can find the proper microenvironment irrespective of the route of administration.
Copyright © 2010 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643182     DOI: 10.1016/j.exphem.2010.07.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

Review 1.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

Review 2.  Advances in umbilical cord blood manipulation-from niche to bedside.

Authors:  Troy C Lund; Anthony E Boitano; Colleen S Delaney; Elizabeth J Shpall; John E Wagner
Journal:  Nat Rev Clin Oncol       Date:  2014-12-16       Impact factor: 66.675

3.  Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection.

Authors:  Fang Wang; Masanori Nojima; Yusuke Inoue; Kuni Ohtomo; Shigeru Kiryu
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

4.  Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation.

Authors:  Bianca Nowlan; Kathryn Futrega; Elizabeth Deborah Williams; Michael Robert Doran
Journal:  Stem Cell Res Ther       Date:  2021-04-12       Impact factor: 6.832

5.  Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment.

Authors:  Sydney Felker; Archana Shrestha; Jeff Bailey; Devin M Pillis; Dylan Siniard; Punam Malik
Journal:  JCI Insight       Date:  2022-05-09

6.  Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice.

Authors:  Kathryn Futrega; William B Lott; Michael R Doran
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.